SEC Company Response from MetaVia Inc. (MTVA) (CIK 0001638287) (MTVA) — Jul 8, 2016
MetaVia Inc. (MTVA) (CIK 0001638287)
Date: July 8, 2016 · CIK: 0001638287 · Accession: 0001104659-16-131764
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-210815
Letter
July 8, 2016
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Suzanne Hayes
Joshua Samples
Lilyanna Peyser
Sharon Blume
Sasha Parikh
Re: Gemphire Therapeutics Inc.
Registration Statement on Form S-1 (File No. 333-210815)
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on June 20, 2016, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for June 22, 2016 at 4:00 p.m. Eastern time or as soon thereafter as practicable in accordance with Rule 461 of the Securities Act of 1933, as amended.
As representatives of the several underwriters of the proposed public offering, we hereby respectfully withdraw our request for acceleration of the effectiveness of the above-referenced Registration Statement set forth in our June 20, 2016 letter.
[signature page follows]
Very truly yours,
JEFFERIES LLC
Show Raw Text
CORRESP 1 filename1.htm July 8, 2016 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Suzanne Hayes Joshua Samples Lilyanna Peyser Sharon Blume Sasha Parikh Re: Gemphire Therapeutics Inc. Registration Statement on Form S-1 (File No. 333-210815) Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on June 20, 2016, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for June 22, 2016 at 4:00 p.m. Eastern time or as soon thereafter as practicable in accordance with Rule 461 of the Securities Act of 1933, as amended. As representatives of the several underwriters of the proposed public offering, we hereby respectfully withdraw our request for acceleration of the effectiveness of the above-referenced Registration Statement set forth in our June 20, 2016 letter. [signature page follows] Very truly yours, JEFFERIES LLC RBC CAPITAL MARKETS, LLC As representatives of the several underwriters JEFFERIES LLC By: /s/ Ashley Delp Walker Name: Ashley Delp Walker Title: Managing Director RBC CAPITAL MARKETS, LLC By: /s/ Lorenzo Paoletti Name: Lorenzo Paoletti Title: Director cc: Mina Sooch, Gemphire Therapeutics Inc. Phillip D. Torrence, Honigman Miller Schwartz and Cohn LLP Meredith Ervine, Honigman Miller Schwartz and Cohn LLP Gabrielle L. Sims, Honigman Miller Schwartz and Cohn LLP Divakar Gupta, Cooley LLP Charles S. Kim, Cooley LLP Siana E. Lowrey, Cooley LLP [Signature Page to Withdrawal of Underwriters’ Acceleration Request]